ReWalk Robotics (NASDAQ:LFWD) Now Covered by Analysts at Laidlaw

Laidlaw initiated coverage on shares of ReWalk Robotics (NASDAQ:LFWDFree Report) in a report issued on Monday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $10.00 price objective on the stock.

Separately, HC Wainwright reissued a “buy” rating and set a $13.00 target price on shares of ReWalk Robotics in a report on Wednesday, November 13th.

Check Out Our Latest Research Report on LFWD

ReWalk Robotics Stock Up 33.6 %

Shares of NASDAQ:LFWD opened at $1.87 on Monday. ReWalk Robotics has a 12-month low of $1.25 and a 12-month high of $7.70. The company’s 50 day moving average price is $1.72 and its two-hundred day moving average price is $2.53. The firm has a market cap of $16.47 million, a PE ratio of -0.75 and a beta of 2.05.

ReWalk Robotics (NASDAQ:LFWDGet Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.08). The company had revenue of $6.13 million for the quarter, compared to analyst estimates of $8.38 million. ReWalk Robotics had a negative return on equity of 43.02% and a negative net margin of 77.21%. During the same period in the prior year, the company earned ($0.56) EPS. On average, research analysts expect that ReWalk Robotics will post -1.78 EPS for the current year.

Insider Transactions at ReWalk Robotics

In other news, major shareholder Global Fund Lp Lind II sold 381,676 shares of the business’s stock in a transaction on Monday, January 6th. The stock was sold at an average price of $3.36, for a total transaction of $1,282,431.36. Following the completion of the transaction, the insider now owns 1,049,430 shares of the company’s stock, valued at approximately $3,526,084.80. The trade was a 26.67 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michael Swinford acquired 21,622 shares of ReWalk Robotics stock in a transaction that occurred on Monday, November 25th. The stock was acquired at an average cost of $2.03 per share, for a total transaction of $43,892.66. Following the completion of the purchase, the director now directly owns 65,040 shares of the company’s stock, valued at $132,031.20. This represents a 49.80 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders bought 61,000 shares of company stock valued at $115,279. Company insiders own 2.50% of the company’s stock.

Institutional Investors Weigh In On ReWalk Robotics

An institutional investor recently bought a new position in ReWalk Robotics stock. Dimensional Fund Advisors LP bought a new position in shares of ReWalk Robotics Ltd. (NASDAQ:LFWDFree Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned about 0.16% of ReWalk Robotics as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 26.76% of the company’s stock.

ReWalk Robotics Company Profile

(Get Free Report)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.

See Also

Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.